Effective Treatment of Refractory CMV Reactivation After Allogeneic Stem Cell Transplantation With In Vitro-generated CMV pp65-specific CD8+ T-cell Lines-Reference-Cited by-同舟云学术

Effective Treatment of Refractory CMV Reactivation After Allogeneic Stem Cell Transplantation With In Vitro-generated CMV pp65-specific CD8+ T-cell Lines

Published:2012-10 Issue:8 Volume:35 Page:621-628
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:

Author:

Meij Pauline,Jedema Inge,Zandvliet Maarten L.,van der Heiden Pim L. J.,van de Meent Marian,van Egmond H. M. Esther,van Liempt Ellis,Hoogstraten Conny,Kruithof Simone,Veld Sabrina,Marijt Erik W. A.,von dem Borne Peter A.,Lankester Arjan C.,Halkes Constantijn J. M.,Falkenburg J. H. Frederik

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of adoptive T‐cell therapy in treating cytomegalovirus infections post‐haematopoietic stem cell transplantation: A systematic review and meta‐analysis;Reviews in Medical Virology;2024-06-15

2. Refractory cytomegalovirus infections in Chinese patients receiving allogeneic hematopoietic cell transplantation: a review of the literature;Frontiers in Immunology;2023-12-22

3. Prospects of Cytomegalovirus-Specific T-Cell Receptors in Clinical Diagnosis and Therapy;Viruses;2023-06-07

4. Tracking the progeny of adoptively transferred virus-specific T cells in patients posttransplant using TCR sequencing;Blood Advances;2023-03-03

5. Pathogen-specific T Cells: Targeting Old Enemies and New Invaders in Transplantation and Beyond;HemaSphere;2023-01